
[Chart courtesy of MarketWatch.com]
1. Moving the Markets
The bulls continued charging forward this Thursday. The start to the year for stocks was a downer, but a February renaissance for stocks continued, as all three major indexes rocketed back into positive territory. Today, investors plowed money back into stocks following a slump the week before, encouraged by a 4% jump in the price of crude oil and Pfizer’s $16 billion deal to buy the drugmaker Hospira.
Drug giant Pfizer (PFE) said it would buy Hospira (HSP), a maker of injectable drugs, for $90 a share in cash. The deal is the first by Pfizer since it walked away from a merger with AstraZeneca last year.
Oil continued its climb today, moving up 4% to reestablish itself at the $50/barrel mark. This made well for energy stocks across the board.
In earnings news, Sprint (S) reported a loss during its Q3 of 2014, but the wireless carrier said it added nearly 1 million new customers during the same timeframe. Apparently, that was enough to send the stock up 5.2% to $4.82 on the day.
In the EuroZone, Greece’s new left-wing government is insisting it will stick to its anti-austerity agenda; hours after the European Central Bank tightened the screws on Athens by withdrawing a key borrowing option for the country’s banks. Greek stocks dropped 3% on the news.
All of our 10 ETFs in the Spotlight enjoyed the newly found upward momentum by closing higher with healthcare (XLV) leading the pack. 2 new highs were made and 9 are now positioned on the plus side YTD.
Read More